Nav: Home

Lung cell transplant boosts healing after the flu in mice

August 20, 2019

Some cases of the flu are so severe they cause lasting injury to the lungs. New research from the University of Pennsylvania now points to a strategy that may one day offer protection against this damage.

The scientists found that transplanting a certain type of lung cell from healthy mice to those that had been injured by an infection with influenza could improve healing. The transplant--achieved by taking specialized lung cells called alveolar type-two (AT2) cells from the healthy animals and then allowing the sick animals to simply breathe in the cells--led to improved blood-oxygen levels.

"We took this really simple approach," says Andrew Vaughan, senior author on the paper and an assistant professor in Penn's School of Veterinary Medicine, "and asked if we could supplement back these AT2 cells into injured mice, can we make them better, can we improve lung regeneration?"

"Imagine if this were in humans," adds Aaron Weiner, lead author on the study and a graduate student in Vaughan's lab. "If there were a bad flu season coming up, it could be routine to say, can you take some of my AT2 cells, grow them up for me, and if I get sick you can just put them back in to help me recover. That biobank idea is what we're imagining."

The study appears in the journal Regenerative Medicine.

Earlier work by Vaughan and colleagues had focused on the negative outcomes that can arise following injury to the lung, such as a serious infection. In the current investigation, they attempted to recreate a healthy recovery in mice that had been infected with the flu. The healing process involves AT2 cells, which normally produce surfactant, a substance that lowers surface tension in the lung's alveoli to ensure proper function. But AT2 cells can also take on a stem cell-like activity, able to both self-renew and to give rise to alveolar type 1 (AT1) cells, which are responsible for gas exchange in the lungs.

Weiner, Vaughan, and colleagues decided to try to take advantage of this ability of AT2 cells to see if they could aid healing.

They first developed a method to grow AT2 cells taken from healthy mice in culture, and then transplant those cells into mice 11 days after being infected with influenza. Nearly two weeks after the transplant, the researchers found that the cells had grown in the recipient's lungs but either remained as AT2 cells or developed markers associated with unhealthy regeneration.

Trying a different tack, the team took roughly a million AT2 cells isolated from healthy mice and directly transplanted them to sick ones. This approach had more success.

"Only a few thousand of the cells stick around in the lungs," says Weiner. "But the important thing we show is that two weeks after we transplant these cells, we see these huge engraftments where the AT2 cells have proliferated a ton and differentiated into the oxygen-exchanging AT1 cells."

"If you weren't looking for the fluorescent tag that we put on the transplanted cells, you wouldn't even be able to distinguish them from the normal tissue," Vaughan says.

The transplant also had a physiological benefit, the researchers demonstrated. Mice that got the transplant of primary AT2 cells had significantly higher blood-oxygen saturation than mice that got a "mock" transplant of saline solution, a sign of a stronger recovery.

"These engraftments are very long-lived," Weiner notes. "One hundred days after the transplant, we find engraftments that are really robust and maintain the cell lineage and have presumably helped in some way for the mice to get better."

As a final test of their methods, the team transplanted AT2 cells into mice that had experience other types of lung injury, including acid inhalation, chemotherapy exposure, and bacterial pneumonia.

"To our surprise it worked really well in two of the three injury models we tested," Vaughan says. They saw robust engraftment after both acid inhalation and chemotherapy, though not for bacterial pneumonia.
-end-
The researchers are following up on their findings with work that looks at the molecular signals that may be encouraging the transplanted cells to stick around after transplant and encourage healthy changes in the lungs. They're also collaborating with colleagues to try to use human cells in a mouse model with an eye toward seeing whether a similar therapy could eventually be translated to use in people.

Andrew E. Vaughan is an assistant professor in the Department of Biomedical Sciences in the University of Pennsylvania School of Veterinary Medicine.

Aaron I. Weiner is a doctoral candidate in the Vaughan laboratory at the University of Pennsylvania.

Weiner and Vaughan coauthored the study with Sergio R. Jackson, Gan Zhao, Kwaku K. Quansah, Joseph N. Farshchian, and Katherine M. Neupauer of Penn Vet; and Elizabeth Q. Littauer, Andrew J. Paris, Derek C. Liberti, G. Scott Worthen, and Edward E. Morrisey of Penn's Perelman School of Medicine.

The study was supported by the National Institutes of Health (Grant HL131817).

University of Pennsylvania

Related Science Articles:

75 science societies urge the education department to base Title IX sexual harassment regulations on evidence and science
The American Educational Research Association (AERA) and the American Association for the Advancement of Science (AAAS) today led 75 scientific societies in submitting comments on the US Department of Education's proposed changes to Title IX regulations.
Science/Science Careers' survey ranks top biotech, biopharma, and pharma employers
The Science and Science Careers' 2018 annual Top Employers Survey polled employees in the biotechnology, biopharmaceutical, pharmaceutical, and related industries to determine the 20 best employers in these industries as well as their driving characteristics.
Science in the palm of your hand: How citizen science transforms passive learners
Citizen science projects can engage even children who previously were not interested in science.
Applied science may yield more translational research publications than basic science
While translational research can happen at any stage of the research process, a recent investigation of behavioral and social science research awards granted by the NIH between 2008 and 2014 revealed that applied science yielded a higher volume of translational research publications than basic science, according to a study published May 9, 2018 in the open-access journal PLOS ONE by Xueying Han from the Science and Technology Policy Institute, USA, and colleagues.
Prominent academics, including Salk's Thomas Albright, call for more science in forensic science
Six scientists who recently served on the National Commission on Forensic Science are calling on the scientific community at large to advocate for increased research and financial support of forensic science as well as the introduction of empirical testing requirements to ensure the validity of outcomes.
World Science Forum 2017 Jordan issues Science for Peace Declaration
On behalf of the coordinating organizations responsible for delivering the World Science Forum Jordan, the concluding Science for Peace Declaration issued at the Dead Sea represents a global call for action to science and society to build a future that promises greater equality, security and opportunity for all, and in which science plays an increasingly prominent role as an enabler of fair and sustainable development.
PETA science group promotes animal-free science at society of toxicology conference
The PETA International Science Consortium Ltd. is presenting two posters on animal-free methods for testing inhalation toxicity at the 56th annual Society of Toxicology (SOT) meeting March 12 to 16, 2017, in Baltimore, Maryland.
Citizen Science in the Digital Age: Rhetoric, Science and Public Engagement
James Wynn's timely investigation highlights scientific studies grounded in publicly gathered data and probes the rhetoric these studies employ.
Science/Science Careers' survey ranks top biotech, pharma, and biopharma employers
The Science and Science Careers' 2016 annual Top Employers Survey polled employees in the biotechnology, biopharmaceutical, pharmaceutical, and related industries to determine the 20 best employers in these industries as well as their driving characteristics.
Three natural science professors win TJ Park Science Fellowship
Professor Jung-Min Kee (Department of Chemistry, UNIST), Professor Kyudong Choi (Department of Mathematical Sciences, UNIST), and Professor Kwanpyo Kim (Department of Physics, UNIST) are the recipients of the Cheong-Am (TJ Park) Science Fellowship of the year 2016.
More Science News and Science Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: The Power Of Spaces
How do spaces shape the human experience? In what ways do our rooms, homes, and buildings give us meaning and purpose? This hour, TED speakers explore the power of the spaces we make and inhabit. Guests include architect Michael Murphy, musician David Byrne, artist Es Devlin, and architect Siamak Hariri.
Now Playing: Science for the People

#576 Science Communication in Creative Places
When you think of science communication, you might think of TED talks or museum talks or video talks, or... people giving lectures. It's a lot of people talking. But there's more to sci comm than that. This week host Bethany Brookshire talks to three people who have looked at science communication in places you might not expect it. We'll speak with Mauna Dasari, a graduate student at Notre Dame, about making mammals into a March Madness match. We'll talk with Sarah Garner, director of the Pathologists Assistant Program at Tulane University School of Medicine, who takes pathology instruction out of...
Now Playing: Radiolab

What If?
There's plenty of speculation about what Donald Trump might do in the wake of the election. Would he dispute the results if he loses? Would he simply refuse to leave office, or even try to use the military to maintain control? Last summer, Rosa Brooks got together a team of experts and political operatives from both sides of the aisle to ask a slightly different question. Rather than arguing about whether he'd do those things, they dug into what exactly would happen if he did. Part war game part choose your own adventure, Rosa's Transition Integrity Project doesn't give us any predictions, and it isn't a referendum on Trump. Instead, it's a deeply illuminating stress test on our laws, our institutions, and on the commitment to democracy written into the constitution. This episode was reported by Bethel Habte, with help from Tracie Hunte, and produced by Bethel Habte. Jeremy Bloom provided original music. Support Radiolab by becoming a member today at Radiolab.org/donate.     You can read The Transition Integrity Project's report here.